vs

Side-by-side financial comparison of Cerence Inc. (CRNC) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $115.1M, roughly 1.7× Cerence Inc.). REPLIGEN CORP runs the higher net margin — 6.7% vs -4.6%, a 11.3% gap on every dollar of revenue. On growth, Cerence Inc. posted the faster year-over-year revenue change (126.1% vs 13.6%). Cerence Inc. produced more free cash flow last quarter ($35.6M vs $17.6M). Over the past eight quarters, Cerence Inc.'s revenue compounded faster (30.3% CAGR vs 14.4%).

Cerence Inc. is an American multinational software company that develops artificial intelligence (AI) assistant technology primarily for automobiles.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

CRNC vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.7× larger
RGEN
$197.9M
$115.1M
CRNC
Growing faster (revenue YoY)
CRNC
CRNC
+112.5% gap
CRNC
126.1%
13.6%
RGEN
Higher net margin
RGEN
RGEN
11.3% more per $
RGEN
6.7%
-4.6%
CRNC
More free cash flow
CRNC
CRNC
$18.1M more FCF
CRNC
$35.6M
$17.6M
RGEN
Faster 2-yr revenue CAGR
CRNC
CRNC
Annualised
CRNC
30.3%
14.4%
RGEN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CRNC
CRNC
RGEN
RGEN
Revenue
$115.1M
$197.9M
Net Profit
$-5.2M
$13.3M
Gross Margin
86.3%
52.5%
Operating Margin
25.5%
9.0%
Net Margin
-4.6%
6.7%
Revenue YoY
126.1%
13.6%
Net Profit YoY
78.4%
143.9%
EPS (diluted)
$-0.12
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRNC
CRNC
RGEN
RGEN
Q4 25
$115.1M
$197.9M
Q3 25
$60.6M
$188.8M
Q2 25
$62.2M
$182.4M
Q1 25
$78.0M
$169.2M
Q4 24
$50.9M
$174.1M
Q3 24
$54.8M
$154.9M
Q2 24
$70.5M
$154.1M
Q1 24
$67.8M
$151.3M
Net Profit
CRNC
CRNC
RGEN
RGEN
Q4 25
$-5.2M
$13.3M
Q3 25
$-13.4M
$14.9M
Q2 25
$-2.7M
$14.9M
Q1 25
$21.7M
$5.8M
Q4 24
$-24.3M
$-30.3M
Q3 24
$-20.4M
$-654.0K
Q2 24
$-313.5M
$3.3M
Q1 24
$-278.0M
$2.1M
Gross Margin
CRNC
CRNC
RGEN
RGEN
Q4 25
86.3%
52.5%
Q3 25
72.6%
53.2%
Q2 25
73.7%
50.0%
Q1 25
77.1%
53.6%
Q4 24
65.0%
26.1%
Q3 24
63.7%
50.0%
Q2 24
71.5%
49.8%
Q1 24
69.2%
49.5%
Operating Margin
CRNC
CRNC
RGEN
RGEN
Q4 25
25.5%
9.0%
Q3 25
-2.9%
8.9%
Q2 25
-1.5%
7.6%
Q1 25
22.2%
3.9%
Q4 24
-33.3%
-17.7%
Q3 24
-35.1%
-5.1%
Q2 24
-503.1%
1.0%
Q1 24
-389.8%
1.3%
Net Margin
CRNC
CRNC
RGEN
RGEN
Q4 25
-4.6%
6.7%
Q3 25
-22.0%
7.9%
Q2 25
-4.4%
8.2%
Q1 25
27.8%
3.4%
Q4 24
-47.7%
-17.4%
Q3 24
-37.3%
-0.4%
Q2 24
-444.5%
2.2%
Q1 24
-409.8%
1.4%
EPS (diluted)
CRNC
CRNC
RGEN
RGEN
Q4 25
$-0.12
$0.24
Q3 25
$-0.26
$0.26
Q2 25
$-0.06
$0.26
Q1 25
$0.46
$0.10
Q4 24
$-0.57
$-0.55
Q3 24
$-0.49
$-0.01
Q2 24
$-7.50
$0.06
Q1 24
$-6.66
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRNC
CRNC
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$2.5M
$767.6M
Total DebtLower is stronger
$171.9M
$542.2M
Stockholders' EquityBook value
$150.4M
$2.1B
Total Assets
$602.0M
$2.9B
Debt / EquityLower = less leverage
1.14×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRNC
CRNC
RGEN
RGEN
Q4 25
$2.5M
$767.6M
Q3 25
$3.4M
$748.7M
Q2 25
$5.5M
$708.9M
Q1 25
$5.4M
$697.2M
Q4 24
$3.9M
$757.4M
Q3 24
$5.5M
$784.0M
Q2 24
$5.4M
$809.1M
Q1 24
$9.4M
$780.6M
Total Debt
CRNC
CRNC
RGEN
RGEN
Q4 25
$171.9M
$542.2M
Q3 25
$199.7M
$537.9M
Q2 25
$198.8M
Q1 25
$257.6M
Q4 24
$256.2M
$525.6M
Q3 24
$281.9M
Q2 24
$280.4M
Q1 24
$278.9M
Stockholders' Equity
CRNC
CRNC
RGEN
RGEN
Q4 25
$150.4M
$2.1B
Q3 25
$150.7M
$2.1B
Q2 25
$155.7M
$2.1B
Q1 25
$149.3M
$2.0B
Q4 24
$120.7M
$2.0B
Q3 24
$141.1M
$2.0B
Q2 24
$154.2M
$2.0B
Q1 24
$463.4M
$2.0B
Total Assets
CRNC
CRNC
RGEN
RGEN
Q4 25
$602.0M
$2.9B
Q3 25
$630.6M
$2.9B
Q2 25
$636.8M
$2.9B
Q1 25
$665.5M
$2.9B
Q4 24
$617.5M
$2.8B
Q3 24
$702.4M
$2.8B
Q2 24
$674.0M
$2.9B
Q1 24
$987.1M
$2.8B
Debt / Equity
CRNC
CRNC
RGEN
RGEN
Q4 25
1.14×
0.26×
Q3 25
1.33×
0.26×
Q2 25
1.28×
Q1 25
1.73×
Q4 24
2.12×
0.27×
Q3 24
2.00×
Q2 24
1.82×
Q1 24
0.60×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRNC
CRNC
RGEN
RGEN
Operating Cash FlowLast quarter
$37.9M
$25.7M
Free Cash FlowOCF − Capex
$35.6M
$17.6M
FCF MarginFCF / Revenue
31.0%
8.9%
Capex IntensityCapex / Revenue
2.0%
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$74.6M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRNC
CRNC
RGEN
RGEN
Q4 25
$37.9M
$25.7M
Q3 25
$12.8M
$48.1M
Q2 25
$23.7M
$28.6M
Q1 25
$15.5M
$15.0M
Q4 24
$9.3M
$39.2M
Q3 24
$6.1M
$49.3M
Q2 24
$12.9M
$42.2M
Q1 24
$1.0M
$44.7M
Free Cash Flow
CRNC
CRNC
RGEN
RGEN
Q4 25
$35.6M
$17.6M
Q3 25
$9.7M
$43.4M
Q2 25
$16.1M
$21.5M
Q1 25
$13.1M
$11.4M
Q4 24
$7.9M
$33.6M
Q3 24
$4.7M
$42.3M
Q2 24
$12.1M
$37.4M
Q1 24
$-801.0K
$36.4M
FCF Margin
CRNC
CRNC
RGEN
RGEN
Q4 25
31.0%
8.9%
Q3 25
16.1%
23.0%
Q2 25
25.8%
11.8%
Q1 25
16.8%
6.8%
Q4 24
15.5%
19.3%
Q3 24
8.5%
27.3%
Q2 24
17.1%
24.3%
Q1 24
-1.2%
24.0%
Capex Intensity
CRNC
CRNC
RGEN
RGEN
Q4 25
2.0%
4.1%
Q3 25
5.0%
2.5%
Q2 25
12.3%
3.9%
Q1 25
3.0%
2.1%
Q4 24
2.7%
3.2%
Q3 24
2.6%
4.5%
Q2 24
1.1%
3.1%
Q1 24
2.7%
5.5%
Cash Conversion
CRNC
CRNC
RGEN
RGEN
Q4 25
1.93×
Q3 25
3.23×
Q2 25
1.92×
Q1 25
0.71×
2.57×
Q4 24
Q3 24
Q2 24
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CRNC
CRNC

License$87.8M76%
Connected Services$14.5M13%
Professional Services$12.8M11%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons